CEL SCI CORP

CVM · NYSE · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.0B · 44 employees
325
SEC Filings
$1.49
Close 2026-09-11
44
Employees

Business Summary

CEL-SCI Corporation is a late clinical-stage biotechnology company focused on cancer immunotherapy and immune system-based treatments. Its lead product candidate, Multikine (Leukocyte Interleukin, Injection), is a Phase 3 investigational immunotherapy for advanced primary head and neck squamous cell carcinoma, administered before surgery. CEL-SCI also develops L.E.A.P.S. technology for potential treatment of rheumatoid arthritis. No products have been approved by the FDA or any regulatory agency.

Latest Stock Quote

CVM 2026-09-11 $1.49 O:$1.55 H:$1.55 L:$1.46 Vol:0.1M VWAP:$1.4942
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-22

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-12-292025-09-300001654954-25-014303EDGAR62K words
2025-01-132024-09-300001654954-25-000288EDGAR60K words
2023-12-212023-09-300001654954-23-015877EDGAR61K words
2022-12-272022-09-300001654954-22-016959EDGAR62K words
2021-12-212021-09-300001654954-21-013417EDGAR63K words
2020-12-292020-09-300001654954-20-013975EDGAR64K words
2019-12-162019-09-300001654954-19-013971EDGAR60K words
2018-12-192018-09-300001654954-18-014104EDGAR57K words
2017-12-292017-09-300001654954-17-011928EDGAR62K words
2016-12-142016-09-300001654954-16-004867EDGAR63K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-142026-06-300001654954-26-007657EDGAR20K words
2026-02-172025-12-310001654954-26-001319EDGAR17K words
2025-08-142025-06-300001654954-25-009568EDGAR19K words
2025-05-142025-03-310001654954-25-005606EDGAR17K words
2025-02-142024-12-310001654954-25-001578EDGAR15K words
2024-08-142024-06-300001654954-24-010651EDGAR16K words
2024-05-152024-03-310001654954-24-006411EDGAR16K words
2024-02-142023-12-310001654954-24-001793EDGAR14K words
2023-08-102023-06-300001654954-23-010485EDGAR15K words
2023-05-122023-03-310001654954-23-006371EDGAR15K words
2023-02-142022-12-310001654954-23-001725EDGAR13K words
2022-08-122022-06-300001654954-22-011196EDGAR19K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-170001654954-26-007691EDGAR1K words
2025-11-240001654954-25-013412EDGAR29K words
2025-11-050001654954-25-012607EDGAR28K words
2025-08-290001654954-25-010184EDGAR1K words
2025-08-250001654954-25-009966EDGAR1K words
2025-07-140001654954-25-008033EDGAR1K words
2025-05-230001654954-25-006091EDGAR1K words
2025-05-190001654954-25-005876EDGAR1K words
2025-03-180001654954-25-002970EDGAR1K words
2024-12-310001654954-24-016019EDGAR1K words

325 total filings indexed. 293 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

cancer-immunotherapy head-and-neck-cancer-treatment rheumatoid-arthritis-treatment oncology-biologics pd-l1-tumor-expression-(tps-scoring) pet-imaging-for-lymph-node-assessment eortc-validated-qol-instruments kaplan-meier-survival-analysis hazard-ratio-analysis

Company Identity

CIK0000725363
TickerCVM
ExchangeNYSE
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedCO
Websitehttps://www.cel-sci.com
Listed1983-12-08

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: b8e63cb80746258fa3c3001e366de31cf8307dd8dfe8bf21379b7ecb9a236b0e
parent: dc924394b91ee2fdd46ebfebcb6d2359a3e82dd82876e64fa330517840772a18
content hash: d0aa7174544adc04d8b8f8da6cf0e59f6b30660550ca4091d0545c044d2775c7
signed: 2026-10-13T19:00:58.263Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up CVM using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on CVM, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/CVM (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.